This is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition. This stock is trading up 13.8% to $4.45 in recent trading.
Today's Range: $3.86-$4.45
52-Week Range: $2.50-$6.55
Three-Month Average Volume: 99,261
From a technical perspective, GTXI is exploding higher here back above its 50-day moving average of $4.17 with decent volume. This move is quickly pushing shares of GTXI within range of triggering a near-term breakout trade. That trade will hit once GTXI takes out some near-term overhead resistance levels at $4.41 to $4.49 with high volume.
Traders should now look for long-biased trades in GTXI as long as it's trending above its 50-day at $4.17, and then once it sustains a move or close above those breakout levels with volume that hits near or above 99,261 shares. If that breakout hits soon, then GTXI will set up to re-test or possibly take out its next major overhead resistance levels at $4.92 to $5.35.
To see more stocks that are making notable moves higher today, check out the
Stocks Under $10 Moving Higher
portfolio on Stockpickr.
-- Written by Roberto Pedone in Winderemere, Fla.
Follow Stockpickr on
and become a fan on